Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients

Infection. 2021 Apr;49(2):361-365. doi: 10.1007/s15010-020-01442-3. Epub 2020 May 14.

Authors

Souheil Zayet¹, Timothee Klopfenstein², Julien Mercier², N'dri Juliette Kadiane-Oussou², Ludovic Lan Cheong Wah², Pierre-Yves Royer², Lynda Toko², Vincent Gendrin²

Affiliations

¹ Department of Infectious Diseases, Nord Franche-Comte Hospital, 90400, Trévenans, France. souhail.zayet@gmail.com.
² Department of Infectious Diseases, Nord Franche-Comte Hospital, 90400, Trévenans, France.

No abstract available

Publication types

Letter

MeSH terms

Adult
Anosmia / diagnosis*
Anosmia / physiopathology
COVID-19 / diagnosis*
COVID-19 / physiopathology
COVID-19 Nucleic Acid Testing
Dysgeusia / diagnosis*
Dysgeusia / physiopathology
Female
Humans
Male
Middle Aged
Outpatients*
SARS-CoV-2 / genetics
SARS-CoV-2 / isolation & purification
Sensitivity and Specificity